Linkage Biosciences


Transplant Dx


Public Relations


Linkage Biosciences is a molecular diagnostics company developing and marketing products that dramatically improve and expedite complex genetic testing.


How do you fulfill the needs of transplant laboratories and advance the science of transplantation to ultimately improve the lives of thousands of transplant patients worldwide?


We partnered with Linkage Biosciences to explain to U.S. and E.U. laboratories how LinkSēq technology offers a dramatically simplified workflow for detecting Human Leukocyte Antigen (HLA) genes associated with tissue compatibility for organ transplantation. For the more than 70,000 patients waiting for organ transplants in Europe alone, rapid and reliable organ and tissue testing is critical.


Through a series of strategic corporate announcements and trade media coverage, the uniquely fast setup and turnaround time for complete molecular genotyping results was communicated to laboratories looking to simply workflows, avoid post-amplification contamination, and increase laboratory productivity. The success of the company resulted in it being acquired by ThermoFisher.

For over a decade Linkage has focused on innovation and quality and so we are pleased to be operating according to the highest international standards.

Zachary Antovich – Founder & CEO, Linkage Biosciences announcing CE Mark for world’s first real-time PCR HLA test


milestones announced


country coordinated media


EU patients potentially assisted

This is a unique website which will require a more modern browser to work!

Please upgrade today!